Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
T. Rowe Price Small-Mid Cap ETF (TMSL) belongs to the US Multi-Factor segment. NYLI Candriam U.S. Mid Cap Equity ETF (IQSM) is part of the US Mid Cap segment. TMSL's top 3 sector exposures are Industrials, Information Technology and Financials. In contrast, IQSM's top sector exposures are Industrials, Information Technology and Health Care. TMSL is more expensive with a Total Expense Ratio (TER) of 0.55%, versus 0.16% for IQSM. TMSL is up 3.8% year-to-date (YTD) with +$353M in YTD flows. IQSM performs worse with 1.9% YTD performance, and +$61M in YTD flows. Run a side-by-side ETF comparison of TMSL and IQSM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | TMSL IQSM | -5.30%-4.41% | +0.86%+0.05% | +3.80%+1.90% | +24.26%+17.13% | n/a+39.89% | n/an/a |
| Flows | TMSL IQSM | +$144M+$45M | +$380M+$60M | +$353M+$61M | +$893M+$44M | -+$219M | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | TMSL IQSM | +16.65%+14.56% | +21.54%+20.37% | n/a+17.45% | n/an/a |
| Max drawdown | TMSL IQSM | -6.80%-5.34% | -16.11%-15.27% | n/a-23.67% | n/an/a |
| Max drawdown duration | TMSL IQSM | 13d13d | 46d46d | n/a379d | n/an/a |
TMSL | IQSM | |
Last sale 3/13/2026 at 1:30 PM | $36.29 | $34.49 |
| Previous close 03/12/2026 | $36.16 | $34.57 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
TMSL | IQSM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
TMSL | IQSM | |
|---|---|---|
| Last price | $36.29 | $34.49 |
| 1D performance | +0.36% | -0.25% |
| AuM | $1.57 B | $270.02 M |
| E/R | 0.55% | 0.16% |
TMSL | IQSM | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | T. Rowe Price | New York Life Investments |
| Benchmark | - | NYLI Candriam U.S. Mid Cap Equity Index |
| N° of holdings | 225 | 219 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 15, 2023 | October 25, 2022 |
| ESG | No | Yes |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.